Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol‐3‐kinase inhibitors: A systematic review and meta‐analysis of randomized controlled trials.

Autor: Wang, Yushu1,2 (AUTHOR), Ma, Zhuo1 (AUTHOR), An, Zhuoling1 (AUTHOR), Zhang, Yi1,2 (AUTHOR), Feng, Xin2 (AUTHOR) fengxin1115@ccmu.edu.cn, Yu, Xiaojia1 (AUTHOR) rope2003yu@163.com
Zdroj: Cancer Medicine. Feb2023, Vol. 12 Issue 3, p2227-2237. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje